Whereas our group previously reported the protective effect of ACE2 replacement in Col4a3–/– mice [16], the augmentation of circulating ACE2 was not able to delay the development of diabetic nephropathy [26,27]. This evidence concerns the gene COL4A3 and diabetic kidney disease.